Skip to main content
Clinical Trials/NCT02260167
NCT02260167
Completed
Not Applicable

Effective Treatment of Alzheimer's and Dementia With the MIND Protocol

Practitioners Alliance Network1 site in 1 country25 target enrollmentSeptember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's Disease
Sponsor
Practitioners Alliance Network
Enrollment
25
Locations
1
Primary Endpoint
Montreal Cognitive Assessment (MoCA)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Treating with measures that may improve metabolic functioning of neurons in an integrated protocol

Detailed Description

Most organ failure results in modest drops in function until over 50% of function is lost. At a certain point, even modest drops in physiologic activity result in dramatic drops in clinical function. Though less homogeneous than in other organs, clinical experience and the literature suggests a similar process occurs in the brain. The hypothesis is that by using an integrated protocol to, essentially, "tune up" neuronal function, a 5-10 % improvement in metabolic functioning may translate to significant improvement in clinical functioning. This tune-up will include "MIND": M- Metabolism-- optimizing hormonal function I- Infections-- looking for and eliminating N- Nutritional and herbal support D- Drugs- Weaning subjects off unneeded medications

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
December 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Practitioners Alliance Network
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A diagnosis of Alzheimer's and/or dementia with an MMSE score over 12 or being ambulatory and able to travel outside the home with assistance.
  • Must have a caregiver living with them.

Exclusion Criteria

  • Overt progressive and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
  • Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months

Outcomes

Primary Outcomes

Montreal Cognitive Assessment (MoCA)

Time Frame: 6 months

Looking to see what percent of patients show improvement

Secondary Outcomes

  • Alzheimer's Disease Assessment Scale- Activities of Daily Living (ADAS-ADL)(6 months)
  • Mini Mental Status Exam (MMSE)(6 months)

Study Sites (1)

Loading locations...

Similar Trials